| http://www.w3.org/ns/prov#value | - Patients eligible for enrollment in the INOVATE-HF clinical trial are those diagnosed with New York Heart Association stage III ???moderate??? heart failure, who even though they are being treated with several combination medications, they continue to have debilitating symptoms including fatigue, shortness of breath, and abnormal heart arrhythmias.
|
